Basket | Login | Register

 
 
 
 

Brexpiprazole (coming soon)

Phase III trials

Scientific title

A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type

Study sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Disease

Subjects with agitation associated with dementia of the Alzheimer's type

Phase

Phase III

Name of drug

Brexpiprazole

Link to full text

https://clinicaltrials.gov/ct2/show/study/NCT03548584?term=Rexulti&cond=Alzheimer+Disease&rank=3&show_locs=Y#locn

Please note that an accessible easy read version of this study is not yet available. The pharmaceutical company running this trial and a member of the European Working Group of People with Dementia are currently reviewing this document.

 

 
 

Last Updated: Wednesday 05 June 2019

 

 
 

Options